GLENMARK PHARMACEUTICALS SK, s. r. o.

Active
IČO 35933526limited liability company (s.r.o.)Founded 2005Bratislava

Key figures

16 607 346 €-17,6%
Revenue 2026
+6,6%
Average annual growth 2021–2026
010 m20 m30 m202120222023202420252026

Key figures

2026

Summary: GLENMARK PHARMACEUTICALS SK, s. r. o.

What kind of company is it?

GLENMARK PHARMACEUTICALS SK, s. r. o. (IČO 35933526) is a limited liability company (s.r.o.). The company was incorporated in 2005 and has existed for 21 years. Registered office according to the register: Bratislava. Main activity according to the Statistical Office: veľkoobchod s farmaceutickým a zdravotníckym tovarom (SK NACE 4646). Size category by number of employees: 25–49 employees.

Who runs the company and who owns it?

The statutory body has 3 members. According to the register, the company has one shareholder. The registered capital is 6 639 €.

How is the company doing financially?

Revenue for 2026 was 16 607 346 €, down 17,6 % on the previous year (20 153 595 €). From 2021 to 2026, revenue grew by an average of 6,6 % per year. Net profit for 2026 was 112 693 € (0,7 % of revenue). The company was profitable in all 6 reported years. Personnel costs for 2026 were 2 135 870 €. At the end of 2026 the company had total assets of 9 693 261 € and equity of 3 276 134 € (equity ratio 33,8 %).

Where does the data come from and how current is it?

Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 17. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.

Summary of annual reports2021–2026
20222023202420252026
Revenue (net turnover)13 631 76015 335 60617 786 01020 153 59516 607 346
Profit for the reporting year276 603498 040197 8811 070 253112 693
Retained earnings of previous periods-86 638189 965688 005885 8861 956 138
Total assets6 654 2068 188 5789 439 3248 937 7269 693 261
Total liabilities5 256 9386 293 2707 346 1355 774 2846 417 127
Total equity1 397 2681 895 3082 093 1893 163 4423 276 134
Calculated dividends00000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Documents in the Register of Financial Statements20

Similar companies

Same industry (SK NACE 4646)
GLENMARK PHARMACEUTICALS SK, s. r. o. (IČO 35933526) – revenue 16,6M €